An Overview of Cognitive Impairment

Clinics in Geriatric Medicine

Volumn 34, Issue 4, 2018, Pages 505-513

  Morley, John E ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Cognition; Dementia; Exercise; Frailty; Olive oil

Indexed keywords

ALZHEIMER DISEASE; COGNITION; COGNITIVE AGING; COGNITIVE DEFECT; DEMENTIA; FRAILTY; FUNCTIONAL DISEASE; HUMAN; MASS SCREENING; MENTAL TEST; MILD COGNITIVE IMPAIRMENT; NONHUMAN; REVIEW; RISK FACTOR; AGED; AGING; CARDIOVASCULAR DISEASE; EXERCISE; HUMAN RELATION; LEARNING; MEDITERRANEAN DIET; PSYCHOLOGY; RISK REDUCTION;

AGED; AGING; CARDIOVASCULAR DISEASES; COGNITIVE DYSFUNCTION; DIET, MEDITERRANEAN; EXERCISE; HUMANS; INTERPERSONAL RELATIONS; LEARNING; RISK REDUCTION BEHAVIOR;

EID: 85051729460     PISSN: 07490690     EISSN: 18798853     Source Type: Journal    
DOI: 10.1016/j.cger.2018.06.003     Document Type: Review

References (64)

1. Willoughby, R.R., Incidental learning. J Educ Psychol 20 (1929), 671–682.
2. Birren, J.E., The significance of age changes in speed of perception and psychomotor response. Anderson, T.E., (eds.) Psychological aspect of aging, 1956, American Psychological Association, Washington, DC, 97–104.
3. Salthouse, T.A., The processing-speed theory of adult age differences in cognition. Psychol Rev 103 (1996), 403–428.
4. Salthouse, T.A., Selective review of cognitive aging. J Int Neuropsychol Soc 16 (2010), 754–760.
5. McCarrey, A.C., An, Y., Kitner-Triolo, M.H., et al. Sex differences in cognitive trajectories in clinically normal older adults. Psychol Aging 31 (2016), 166–175.
6. Dellinger, E.P., Pellegrini, C., Gallagher, T.H., The aging physician and the medical profession: a review. JAMA Surg 152 (2017), 967–971.
7. Kaups, K.L., Competence not age determines ability to practice: ethical considerations about sensorimotor agility, dexterity, and cognitive capacity. AMA J Ethics 18 (2016), 1017–1024.
8. Raz, N., Daugherty, A.M., Pathways to brain aging and their modifiers: free-radical-induced energetic and neural decline in senescence (FRIENDS) model–a mini-review. Gerontology, 2017, 10.1159/000479508.
9. Boccardi, V., Comanducci, C., Baroni, M., et al. Of energy and entropy: the ineluctable impact of aging in old age dementia. Int J Mol Sci, 18, 2017, 2672.
10. Chandran, R., Kumar, M., Kesavan, L., et al. Cellular calcium signaling in the aging brain. J Chem Neuroanat, 2017, 10.1016/j.jchemneu.2017.17.006.
11. Skullerud, K., Variations in the size of the human brain. Influence of age, sex, body length, body mass index, alcoholism, Alzheimer changes, and cerebral atherosclerosis. Acta Neurol Scand Suppl 102 (1985), 1–94.
12. Grimm, A., Eckert, A., Brain aging and neurodegeneration: from a mitochondrial point of view. J Neurochem 143 (2017), 418–431.
13. Mooradian, A.D., Morin, A.M., Cipp, L.J., et al. Glucose transport is reduced in the blood-brain barrier of aged rats. Brain Res 14 (1991), 145–149.
14. Yin, F., Sancheti, H., Patil, I., et al. Energy metabolism and inflammation in brain aging and Alzheimer's disease. Free Radic Biol Med 100 (2016), 108–122.
15. Tonnies, E., Trushina, E., Oxidative stress, synaptic dysfunction, and Alzheimer's disease. J Alzheimers Dis 57 (2017), 1105–1121.
16. Banks, W.A., Farr, S.A., La Scola, M.E., et al. Intravenous human interleukin-1 alpha impairs memory processing in mice: dependence on blood-brain barrier transport into posterior division of the septum. J Pharmacol Exp Ther 299 (2001), 536–541.
17. Lin, J.S., O'Connor, E., Rossom, R.C., et al. Screening for cognitive impairment in older adults: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 159 (2013), 601–612.
18. Morley, J.E., Morris, J.C., Berg-Weger, M., et al. Brain health: the importance of recognizing cognitive impairment: an IAGG consensus conference. J Am Med Dir Assoc 16 (2015), 731–739.
19. Morley, J.E., Editorial: can we improve care for patients with dementia?. J Nutr Health Aging 15 (2011), 523–525.
20. Abele, P., Morley, J.E., Advance directives: the key to a good death?. J Am Med Dir Assoc 17 (2016), 279–283.
21. Morley, J.E., Mild cognitive impairment—a treatable condition. J Am Med Dir Assoc 15 (2014), 1–5.
22. Birks, J., Harvey, R.J., Donepezil for dementia due to Alzheimer's disease. Cochrane Database Syst Rev(6), 2018 CD001190.
23. Woods, B., Aguirre, E., Spector, A.E., et al. Cognitive stimulation to improve cognitive functioning in people with dementia. Cochrane Database Syst Rev(2), 2012 CD005562.
24. Berg-Weger, M., Tebb, S., Henderson-Kalb, J., et al. Cognitive stimulation therapy: a tool for your practice with persons with dementia?. J Am Med Dir Assoc 16 (2015), 795–796.
25. Morley, J.E., Cruz-Oliver, D.M., Cognitive stimulation therapy. J Am Med Dir Assoc 15 (2014), 689–691.
26. Trivedi, D., Cochrane review summary: Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations. Prim Health Care Res Dev 18 (2017), 527–528.
27. Tariq, S.H., Tumosa, N., Chibnall, J.T., et al. Comparison of the Saint Louis University mental status examination and the mini-mental state examination for detecting dementia and mild neurocognitive disorder—a pilot study. Am J Geriatr Psychiatry 14 (2006), 900–910.
28. Cummings-Vaughn, L.A., Chavakula, N.N., Malmstrom, T.K., et al. Veterans Affairs Saint Louis University mental status examination compared with the Montreal Cognitive Assessment and the Short Test of Mental Status. J Am Geriatr Soc 62 (2014), 1341–1346.
29. Shaik, M.A., Chan, Q.L., Xu, J., et al. Risk factors of cognitive impairment and brief cognitive tests to predict cognitive performance determined by a formal neuropsychological evaluation of primary health care patients. J Am Med Dir Assoc 17 (2016), 343–347.
30. Borson, S., Scanlan, J.M., Watanabe, J., et al. Simplifying detection of cognitive impairment: comparison of the Mini-Cog and Mini-Mental State Examination in a multiethnic sample. J Am Geriatr Soc 53 (2005), 871–874.
31. Malmstrom, T.K., Voss, V.B., Cruz-Oliver, D.M., et al. The Rapid Cognitive Screen (RCS): a point-of-care screening for dementia and mild cognitive impairment. J Nutr Health Aging 19 (2015), 741–744.
32. Dong, Y., Pang, W.S., Lim, L.B., et al. The informant AD8 is superior to participant AD8 in detecting cognitive impairment in a memory clinic setting. J Alzheimers Dis 35 (2013), 159–168.
33. Morley, J.E., Abele, P., The Medicare Annual Wellness visit in nursing homes. J A Med Dir Assoc 17 (2016), 567–569.
34. Liccini, A., Malmstrom, T.K., Morley, J.E., Metformin use and cognitive dysfunction among patients with diabetes mellitus. J Am Med Dir Assoc 17 (2016), 1063–1065.
35. Petersen, R.C., Clinical practice. Mild cognitive impairment. N Engl J Med 364 (2011), 2227–2234.
36. Gauthier, S., Reisberg, B., Zaudig, M., et al. International Psychogeriatric Association Expert Conference on mild cognitive impairment. Mild cognitive impairment. Lancet 367 (2006), 1262–1270.
37. Petersen, R.C., Roberts, R.O., Knopman, D.S., et al. Prevalence of mild cognitive impairment is higher in men. The Mayo Clinic Study of Aging. Neurology 75 (2010), 889–897.
38. Larrieu, S., Letenneur, L., Orgogozo, J.M., et al. Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology 59 (2002), 1594–1599.
39. Cruz-Oliver, D.M., Malstrom, T.K., Roegner, M., et al. Cognitive deficit reversal as shown by changes in the Veterans Affairs Saint Louis University Mental Status (SLUMS) examination scores 7.5 years later. J Am Med Dir Assoc, 15, 2014, 687.e5-10.
40. Huh, M., The relationships between cognitive function and hearing loss among the elderly. J Phys Ther Sci 30 (2018), 174–176.
41. Thompson, R.S., Auduong, P., Miller, A.T., et al. Hearing loss as a risk factor for dementia: systematic review. Laryngoscope Investig Otolaryngol 2 (2017), 69–79.
42. Loughrey, D.G., Kelly, M.E., Kelley, G.A., et al. Association of age-related hearing loss with cognitive function, cognitive impairment, and dementia: a systematic review and meta-analysis. JAMA Otolaryngol Head Neck Surg, 2017, 10.1001/jamaoto.2017.2513.
43. Malmstrom, T.K., Morley, J.E., The frail brain. J Am Med Dir Assoc 14 (2013), 453–455.
44. Canevelli, M., Cesari, M., Cognitive frailty: what is still missing?. J Nutr Health Aging 19 (2015), 273–275.
45. Shimada, H., Makizako, H., Lee, S., et al. Impact of cognitive frailty on daily activities in older persons. J Nutr Health Aging 20 (2016), 729–735.
46. Malmstrom, T.K., Miller, D.K., Morley, J.E., A comparison of four frailty models. J Am Geriatr Soc 62 (2014), 721–726.
47. Merchant, R.A., Chen, M.Z., Tan, L.W.L., et al. Singapore Healthy Older People Everyday (HOPE) study: prevalence of frailty and associated factors in older adults. J Am Med Dir Assoc, 18, 2017, 734.e9-e14.
48. Morley, J.E., White matter lesions (laukoaraiosis): a major cause of falls. J Am Med Dir Assoc 16 (2015), 441–443.
49. Roppolo, M., Mulasso, A., Rabaglietti, E., Cognitive frailty in Italian community-dwelling older adults: prevalence rate and its association with disability. J Nutr Health Aging 21 (2017), 631–636.
50. Langa, K.M., Larson, E.B., Crimmins, E.M., et al. A comparison of the prevalence of dementia in the United States in 2000 and 2012. JAMA Intern Med 177 (2017), 51–58.
51. Reamy, B.V., Williams, P.M., Kuckel, D.P., Prevention of cardiovascular disease. Prim Care 45 (2018), 25–44.
52. Gretton, C., Ffytche, D.H., Art and the brain: a view from dementia. Int J Geriatr Psychiatry 29 (2014), 111–126.
53. Petersson, S.D., Philippou, E., Mediterranean diet, cognitive function, and dementia: a systematic review of the evidence. Adv Nutr 7 (2016), 889–904.
54. Martinez-Lapiscina, E.H., Clavero, P., Toledo, E., et al. Virgin olive oil supplementation and long-term cognition: the PREDIMED-NAVARRA randomized, trial. J Nutr Health Aging 17 (2013), 544–552.
55. Strohle, A., Schmidt, D.K., Schultz, F., et al. Drug and exercise treatment of Alzheimer disease and mild cognitive impairment: a systematic review and meta-analysis of effects on cognition in randomized controlled trials. Am J Geriatr Psychiatry 23 (2015), 1234–1249.
56. Farr, S.A., Price, T.O., Dominguez, L.J., et al. Extra virgin olive oil improves learning and memory in SAMP8 mice. J Alzheimers Dis 28 (2012), 81–92.
57. Bamidis, P.D., Fissler, P., Papageorgiou, S.G., et al. Gains in cognition through combined cognitive and physical training: the role of training dosage and severity of neurocognitive disorder. Front Aging Neurosci, 7, 2015, 152.
58. Ngandu, T., Lehtisalo, J., Solomon, A., et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet 385 (2015), 2255–2263.
59. Petursdottir, A.L., Farr, S.A., Morley, J.E., et al. Effect of dietary n-3 polyunsaturated fatty acid composition, learning ability, and memory of senescence-accelerated mouse. J Gerontol A Biol Sci Med Sci 63 (2008), 1153–1160.
60. Farr, S.A., Niehoff, M.L., Ceddia, M., et al. Effect of botanical extracts containing carnosic acid or rosmarinic acid on learning and memory in SAMP8 mice. Physiol Behav 165 (2016), 328–338.
61. Goozee, K.G., Shah, T.M., Sohrabi, H.R., et al. Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer's disease. Br J Nutr 115 (2016), 449–465.
62. Kamphius, P.J., Verhey, F.R., Olde Rikkert, M.G., et al. Efficacy of a medical food on cognition in Alzheimer's disease: results from secondary analyses of a randomized, controlled trial. J Nutr Health Aging 15 (2011), 720–724.
63. Moon, S.Y., de Souto Barreto, P., Chupin, M., et al. Association between red blood cells omega-3 polyunsaturated fatty acids and white matter hyperintensities: the MAPT study. J Nutr Health Aging 22 (2018), 174–179.
64. Canhada, S., Castro, K., Perry, I.S., et al. Omega-3 fatty acids’ supplementation in Alzheimer's disease: a systematic review. Nutr Neurosci 3 (2017), 1–10.